• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

1,3-双[2-(2-氧代-1,3-恶唑烷-3-基)乙基]-1H-苯并咪唑-2(3H)-酮

1,3-Bis[2-(2-oxo-1,3-oxazolidin-3-yl)eth-yl]-1H-benzimidazol-2(3H)-one.

作者信息

Ouzidan Younes, Kandri Rodi Youssef, Fronczek Frank R, Venkatraman Ramaiyer, El Ammari Lahcen, Essassi El Mokhtar

出版信息

Acta Crystallogr Sect E Struct Rep Online. 2011 Jan 12;67(Pt 2):o362-3. doi: 10.1107/S1600536810052141.

DOI:10.1107/S1600536810052141
PMID:21523041
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3051530/
Abstract

The mol-ecular structure of the title compound, C(17)H(20)N(4)O(5), contains a central fused-ring system, comprised of six- and five-membered rings. This unit is linked by C(2) chains to two 2-oxo-1,3-oxazolidine five-membered rings. The central fused-ring system is essentially planar, with a maximum deviation of 0.008 (1) Å from the mean plane. Both oxazolidine five-membered rings are also nearly planar, with maximum deviations of 0.090 (1) and 0.141 (1) Å.

摘要

标题化合物C(17)H(20)N(4)O(5)的分子结构包含一个由六元环和五元环组成的中心稠环体系。该单元通过C(2)链与两个2-氧代-1,3-恶唑烷五元环相连。中心稠环体系基本呈平面状，与平均平面的最大偏差为0.008 (1) Å。两个恶唑烷五元环也近乎平面，最大偏差分别为0.090 (1)和0.141 (1) Å。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1822/3051530/663c833a7bc1/e-67-0o362-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1822/3051530/663c833a7bc1/e-67-0o362-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1822/3051530/663c833a7bc1/e-67-0o362-fig1.jpg

相似文献

1
1,3-Bis[2-(2-oxo-1,3-oxazolidin-3-yl)eth-yl]-1H-benzimidazol-2(3H)-one.1,3-双[2-(2-氧代-1,3-恶唑烷-3-基)乙基]-1H-苯并咪唑-2(3H)-酮
Acta Crystallogr Sect E Struct Rep Online. 2011 Jan 12;67(Pt 2):o362-3. doi: 10.1107/S1600536810052141.
2
Crystal structure of 5-chloro-1,3-bis-[2-(2-oxo-1,3-oxazolidin-3-yl)eth-yl]-1H-benz-imidazol-2(3H)-one.5-氯-1,3-双-[2-(2-氧代-1,3-恶唑烷-3-基)乙基]-1H-苯并咪唑-2(3H)-酮的晶体结构
Acta Crystallogr E Crystallogr Commun. 2015 Sep 12;71(Pt 10):o735-6. doi: 10.1107/S2056989015016102. eCollection 2015 Oct 1.
3
3-[2-(3-Methyl-2-oxo-1,2-dihydro-quinoxalin-1-yl)eth-yl]oxazolidin-2-one.3-[2-(3-甲基-2-氧代-1,2-二氢喹喔啉-1-基)乙基]恶唑烷-2-酮
Acta Crystallogr Sect E Struct Rep Online. 2009 Jul 29;65(Pt 8):o2024-5. doi: 10.1107/S1600536809028736.
4
5-Methyl-3-[1-(2-pyridylmeth-yl)-1H-benzimidazol-2-ylmeth-yl]isoxazole.5-甲基-3-[1-(2-吡啶甲基)-1H-苯并咪唑-2-基甲基]异恶唑
Acta Crystallogr Sect E Struct Rep Online. 2009 Oct 10;65(Pt 11):o2714-5. doi: 10.1107/S1600536809040100.
5
6-Bromo-1-[2-(2-oxo-1,3-oxazolidin-3-yl)eth-yl]-1H-imidazo[4,5-b]pyridin-2(3H)-one.6-溴-1-[2-(2-氧代-1,3-恶唑烷-3-基)乙基]-1H-咪唑并[4,5-b]吡啶-2(3H)-酮
Acta Crystallogr Sect E Struct Rep Online. 2010 Jan 27;66(Pt 2):o456. doi: 10.1107/S1600536810002679.
6
2-Eth-oxy-6-{[1-(3-eth-oxy-2-hy-droxy-benz-yl)-1H-benzimidazol-2-yl]meth-yl}phenol nitro-methane monosolvate.2-乙氧基-6-{[1-(3-乙氧基-2-羟基苄基)-1H-苯并咪唑-2-基]甲基}苯酚硝基甲烷单溶剂合物
Acta Crystallogr Sect E Struct Rep Online. 2012 Jun 1;68(Pt 6):o1914. doi: 10.1107/S1600536812023665. Epub 2012 May 31.
7
1-[2-(2-Oxo-1,3-oxazolidin-3-yl)eth-yl]-4-phenyl-1H-1,5-benzodiazepin-2(3H)-one.1-[2-(2-氧代-1,3-恶唑烷-3-基)乙基]-4-苯基-1H-1,5-苯并二氮杂卓-2(3H)-酮
Acta Crystallogr Sect E Struct Rep Online. 2010 Jul 21;66(Pt 8):o2080. doi: 10.1107/S160053681002828X.
8
3-[2-(3-Methyl-quinoxalin-2-yl-oxy)eth-yl]-1,3-oxazolidin-2-one.3-[2-(3-甲基喹喔啉-2-基氧基)乙基]-1,3-恶唑烷-2-酮
Acta Crystallogr Sect E Struct Rep Online. 2010 Apr 10;66(Pt 5):o1050. doi: 10.1107/S1600536810012687.
9
3-[2-(5H-Indolo[2,3-b]quinoxalin-5-yl)eth-yl]-1,3-oxazolidin-2-one.3-[2-(5H-吲哚并[2,3-b]喹喔啉-5-基)乙基]-1,3-恶唑烷-2-酮
Acta Crystallogr Sect E Struct Rep Online. 2010 Aug 28;66(Pt 9):o2461. doi: 10.1107/S1600536810033222.
10
1-Nonyl-1H-benzimidazol-2(3H)-one.1-壬基-1H-苯并咪唑-2(3H)-酮
Acta Crystallogr Sect E Struct Rep Online. 2011 Jan 8;67(Pt 2):o283. doi: 10.1107/S1600536810054164.

引用本文的文献

1
Crystal structure, Hirshfeld surface analysis and DFT studies of 1-benzyl-3-[(1-benzyl-1-1,2,3-triazol-5-yl)meth-yl]-2,3-di-hydro-1-1,3-benzo-diazol-2-one monohydrate.1-苄基-3-[(1-苄基-1H-1,2,3-三唑-5-基)甲基]-2,3-二氢-1H-1,3-苯并二唑-2-酮一水合物的晶体结构、 Hirshfeld表面分析和密度泛函理论研究
Acta Crystallogr E Crystallogr Commun. 2020 Jan 1;76(Pt 1):95-101. doi: 10.1107/S2056989019016876.
2
Crystal structure, Hirshfeld surface analysis and inter-action energy and DFT studies of 1-methyl-3-(prop-2-yn-1-yl)-2,3-di-hydro-1-1,3-benzo-diazol-2-one.1-甲基-3-(丙-2-炔-1-基)-2,3-二氢-1H-1,3-苯并二唑-2-酮的晶体结构、 Hirshfeld表面分析、相互作用能及密度泛函理论研究
Acta Crystallogr E Crystallogr Commun. 2019 Nov 29;75(Pt 12):1940-1946. doi: 10.1107/S2056989019015779. eCollection 2019 Dec 1.
3

本文引用的文献

1
3-[2-(3-Methyl-2-oxo-1,2-dihydro-quinoxalin-1-yl)eth-yl]oxazolidin-2-one.3-[2-(3-甲基-2-氧代-1,2-二氢喹喔啉-1-基)乙基]恶唑烷-2-酮
Acta Crystallogr Sect E Struct Rep Online. 2009 Jul 29;65(Pt 8):o2024-5. doi: 10.1107/S1600536809028736.
2
4-Benzyl-6-bromo-2-phenyl-4H-imidazo[4,5-b]pyridine.4-苄基-6-溴-2-苯基-4H-咪唑并[4,5-b]吡啶
Acta Crystallogr Sect E Struct Rep Online. 2010 Mar 27;66(Pt 4):o946. doi: 10.1107/S160053681001038X.
3
6-Bromo-1-[2-(2-oxo-1,3-oxazolidin-3-yl)eth-yl]-1H-imidazo[4,5-b]pyridin-2(3H)-one.
Crystal structure and Hirshfeld surface analysis of 1-benzyl-3-(prop-2-yn-1-yl)-2,3-di-hydro-1-1,3-benzo-diazol-2-one.1-苄基-3-(丙-2-炔-1-基)-2,3-二氢-1H-1,3-苯并二唑-2-酮的晶体结构与 Hirshfeld 表面分析
Acta Crystallogr E Crystallogr Commun. 2018 Nov 22;74(Pt 12):1842-1846. doi: 10.1107/S2056989018016298. eCollection 2018 Dec 1.
4
Crystal structure and Hirshfeld surface analysis of 1-{[2-oxo-3-(prop-1-en-2-yl)-2,3-di-hydro-1-1,3-benzo-diazol-1-yl]meth-yl}-3-(prop-1-en-2-yl)-2,3-di-hydro-1-1,3-benzo-diazol-2-one.1-{[2-氧代-3-(1-丙烯-2-基)-2,3-二氢-1H-1,3-苯并二氮杂卓-1-基]甲基}-3-(1-丙烯-2-基)-2,3-二氢-1H-1,3-苯并二氮杂卓-2-酮的晶体结构和 Hirshfeld 表面分析
Acta Crystallogr E Crystallogr Commun. 2018 Nov 9;74(Pt 12):1746-1750. doi: 10.1107/S2056989018015219. eCollection 2018 Dec 1.
5
Crystal structure of 5-chloro-1,3-bis-[2-(2-oxo-1,3-oxazolidin-3-yl)eth-yl]-1H-benz-imidazol-2(3H)-one.5-氯-1,3-双-[2-(2-氧代-1,3-恶唑烷-3-基)乙基]-1H-苯并咪唑-2(3H)-酮的晶体结构
Acta Crystallogr E Crystallogr Commun. 2015 Sep 12;71(Pt 10):o735-6. doi: 10.1107/S2056989015016102. eCollection 2015 Oct 1.
6
5-Nitro-1,3-bis-(prop-2-yn-yl)-1H-1,3-benzimidazol-2(3H)-one.5-硝基-1,3-双-(丙-2-炔基)-1H-1,3-苯并咪唑-2(3H)-酮
Acta Crystallogr Sect E Struct Rep Online. 2013 Jun 26;69(Pt 7):o1159. doi: 10.1107/S1600536813016814. eCollection 2013.
7
1-(Prop-2-yn-yl)-1H-benzimidazol-2(3H)-one.1-（2-丙炔基）-1H-苯并咪唑-2（3H）-酮
Acta Crystallogr Sect E Struct Rep Online. 2013 Jan 1;69(Pt 1):o119. doi: 10.1107/S160053681205088X. Epub 2012 Dec 22.
8
1-Decyl-6-nitro-1H-benzimidazol-2(3H)-one.1-癸基-6-硝基-1H-苯并咪唑-2(3H)-酮
Acta Crystallogr Sect E Struct Rep Online. 2011 Nov;67(Pt 11):o2937. doi: 10.1107/S1600536811041389. Epub 2011 Oct 12.
9
1,3-Dibenzyl-1H-benzimidazol-2(3H)-one.1,3-二苄基-1H-苯并咪唑-2(3H)-酮
Acta Crystallogr Sect E Struct Rep Online. 2011 Dec 1;67(Pt 12):o3234. doi: 10.1107/S1600536811046071. Epub 2011 Nov 9.
10
1-Benzyl-1H-benzimidazol-2(3H)-one.1-苄基-1H-苯并咪唑-2(3H)-酮
Acta Crystallogr Sect E Struct Rep Online. 2011 Jul 1;67(Pt 7):o1822. doi: 10.1107/S160053681102455X. Epub 2011 Jun 25.
6-溴-1-[2-(2-氧代-1,3-恶唑烷-3-基)乙基]-1H-咪唑并[4,5-b]吡啶-2(3H)-酮
Acta Crystallogr Sect E Struct Rep Online. 2010 Jan 27;66(Pt 2):o456. doi: 10.1107/S1600536810002679.
4
3-[2-(3-Methyl-quinoxalin-2-yl-oxy)eth-yl]-1,3-oxazolidin-2-one.3-[2-(3-甲基喹喔啉-2-基氧基)乙基]-1,3-恶唑烷-2-酮
Acta Crystallogr Sect E Struct Rep Online. 2010 Apr 10;66(Pt 5):o1050. doi: 10.1107/S1600536810012687.
5
A short history of SHELX.SHELX简史。
Acta Crystallogr A. 2008 Jan;64(Pt 1):112-22. doi: 10.1107/S0108767307043930. Epub 2007 Dec 21.
6
Streptogramins, oxazolidinones, and other inhibitors of bacterial protein synthesis.链阳性菌素、恶唑烷酮类及其他细菌蛋白质合成抑制剂。
Chem Rev. 2005 Feb;105(2):529-42. doi: 10.1021/cr030110z.
7
Oxazolidinones: a review.恶唑烷酮类：综述
Drugs. 2000 Jan;59(1):7-16. doi: 10.2165/00003495-200059010-00002.
8
Bis-benzimidazole anticancer agents: targeting human tumour helicases.双苯并咪唑类抗癌剂：靶向人类肿瘤解旋酶
Anticancer Drug Des. 1999 Feb;14(1):19-36.
9
Selective activation of Ca(2+)-dependent K+ channels by novel benzimidazolone.新型苯并咪唑酮对钙依赖性钾通道的选择性激活
Eur J Pharmacol. 1994 Jan 4;251(1):53-9. doi: 10.1016/0014-2999(94)90442-1.
10
The substituted benzimidazolone NS004 is an opener of the cystic fibrosis chloride channel.
J Biol Chem. 1994 Apr 15;269(15):10983-6.